For developing the COVID Collaboration Platform to bring disparate research teams working on the same clinical research questions together to share protocols, data, and evidence. Outside of a few centrally organized trials, most COVID-19 randomized clinical trials are small and/or redundant-and it's only by aggregating evidence across these trials that we will learn how to best treat COVID-19.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Elizabeth L OgburnResearch Location
United States of AmericaLead Research Institution
Johns Hopkins HospitalResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
For developing the COVID Collaboration Platform to bring disparate research teams working on the same clinical research questions together to share protocols, data, and evidence. Outside of a few centrally organized trials, most COVID-19 randomized clinical trials are small and/or redundant-and it's only by aggregating evidence across these trials that we will learn how to best treat COVID-19.